
Platform overview
Cyber risk, GRC and enterprise oversight on a shared foundation.
14 slides · English
View presentationGENESECURE PRESENTATIONS
Start with the platform overview, then explore 13 modules covering cyber security, enterprise risk, compliance, financial and model risk, resilience, supplier oversight and governed AI.
Explore all GeneSecure presentations
Cyber risk, GRC and enterprise oversight on a shared foundation.
14 slides · English
View presentation
Risk signals become accountable treatments.
10 slides · English
View presentation
A shared record across governance teams.
10 slides · English
View presentation
Control evidence stays connected to the requirement.
10 slides · English
View presentation
Regulatory change reaches the responsible owner.
10 slides · English
View presentation
Financial exposure with traceable assumptions.
10 slides · English
View presentation
Every model has a purpose, owner and review record.
10 slides · English
View presentation
Security findings connect to business exposure.
10 slides · English
View presentation
An explainable view of cyber posture.
10 slides · English
View presentation
Security assurance through controlled disclosure.
10 slides · English
View presentation
Evidence supports every proposed answer.
10 slides · English
View presentation
Recovery planning connects to service dependencies.
10 slides · English
View presentation
Supplier oversight continues beyond onboarding.
10 slides · English
View presentation
Governed AI assistance across the platform.
10 slides · English
View presentationEXPLORE GENESECURE
GeneSecure connects cyber, cloud, identity, vendor, compliance and enterprise-risk information in a shared command center. Its modules bring risk assessment, control evidence and response workflows together, with Cortex AI preparing work for human review.
Bring syslog, endpoint events, cloud audit, and network signals together in a governed store.
Version detections as code, test them against historical events, and hunt across retained telemetry.
Support analyst-led investigation with AI-assisted triage, permission-aware actions, and an audit record of each step.
FROM CAPABILITY TO APPLICATION
Security teams need to connect an alert with the events around it, examine historical activity, and preserve what they learn. GeneSecure uses the GeneData foundation to bring telemetry, detection, investigation, and incident evidence into a governed security workflow.
Bring endpoint, network, cloud, and system events into a shared analytical context. Establish source coverage and data quality so analysts understand what is available during an investigation.
Version detection logic and test it against retained events. Review the evidence behind a match, investigate false positives, and refine the rule through a controlled change process.
Correlate signals, explore historical activity, and organize the evidence behind a case. Use AI-assisted triage within defined permissions while analysts direct the investigation.
PLAN A USEFUL EVALUATION
Bring a representative example, the people who own it, and the requirements it must meet. Review the whole path from input to output, including exceptions and handoffs.
EVALUATE WITH CONFIDENCE
Genellipse plans a focused MVP within 6 weeks. Agree the outcome, interfaces, authorized access, client reviewers, and acceptance criteria before delivery begins.
COMMON QUESTIONS
Explore the scope, practical considerations, and a useful starting point for your team.
GeneSecure is Genellipse’s security operations offering built on GeneData. It applies data ingestion, analytics, governance, and AI capabilities to security telemetry, detection, threat hunting, and investigation.
Begin by mapping the current tools, data flows, and investigation process. The evaluation should establish which systems remain sources, which workflows can be connected, and whether any replacement is appropriate for the agreed scope.
Use representative historical events and agreed scenarios. Assess source coverage, the relevance of alerts, investigation effort, and how clearly an analyst can explain the evidence. Include known benign activity as well as events that should trigger review.
TAKE A CLOSER LOOK
See the product, explore its capabilities, and find your next step.